Skip to main content Accessibility help
×
Home

Ventilator-Associated Pneumonia: Overdiagnosis and Treatment Are Common in Medical and Surgical Intensive Care Units

  • Veronique Nussenblatt (a1), Edina Avdic (a2), Sean Berenholtz (a3) (a4), Elizabeth Daugherty (a5), Eric Hadhazy (a1), Pamela A. Lipsett (a3) (a4), Lisa L. Maragakis (a1), Trish M. Perl (a1), Kathleen Speck (a3), Sandra M. Swoboda (a3), Wendy Ziai (a3) (a6) and Sara E. Cosgrove (a1)...

Abstract

Objective.

Diagnosing ventilator-associated pneumonia (VAP) is difficult, and misdiagnosis can lead to unnecessary and prolonged antibiotic treatment. We sought to quantify and characterize unjustified antimicrobial use for VAP and identify risk factors for continuation of antibiotics in patients without VAP after 3 days.

Methods.

Patients suspected of having VAP were identified in 6 adult intensive care units (ICUs) over 1 year. A multidisciplinary adjudication committee determined whether the ICU team's VAP diagnosis and therapy were justified, using clinical, microbiologic, and radiographic data at diagnosis and on day 3. Outcomes included the proportion of VAP events misdiagnosed as and treated for VAP on days 1 and 3 and risk factors for the continuation of antibiotics in patients without VAP after day 3.

Results.

Two hundred thirty-one events were identified as possible VAP by the ICUs. On day 1, 135 (58.4%) of them were determined to not have VAP by the committee. Antibiotics were continued for 120 (76%) of 158 events without VAP on day 3. After adjusting for acute physiology and chronic health evaluation II score and requiring vasopressors on day 1, sputum culture collection on day 3 was significantly associated with antibiotic continuation in patients without VAP. Patients without VAP or other infection received 1,183 excess days of antibiotics during the study.

Conclusions.

Overdiagnosis and treatment of VAP was common in this study and led to 1,183 excess days of antibiotics in patients with no indication for antibiotics. Clinical differences between non-VAP patients who had antibiotics continued or discontinued were minimal, suggesting that clinician preferences and behaviors contribute to unnecessary prescribing.

Copyright

Corresponding author

Hospital Epidemiology and Infection Control and Antimicrobial Stewardship Program, Johns Hopkins Hospital, 600 North Wolfe Street, Osier 425, Baltimore, MD 21287 (scosgrol@jhmi.edu)

References

Hide All
1. Chastre, J, Fagon, JY. Ventilator-associated pneumonia. Am J Res-pir Crit Care Med 2002;165:867903.
2. Relio, J, Ollendorf, DA, Oster, G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:21152121.
3. Safdar, N, Dezfulian, C, Collard, HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:218493.
4. Warren, DK, Shukla, SJ, Olsen, MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:13121317.
5. Heyland, DK, Cook, DJ, Griffith, L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:12491256.
6. Bercault, N, Boulain, T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29: 23032309.
7. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388416.
8. Iregui, M, Ward, S, Sherman, G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262268.
9. Luna, CM, Vujacich, P, Niederman, MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676685.
10. Fowler, RA, Flavin, KE, Barr, J, et al. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest 2003;123:835844.
11. Eachempati, SR, Hydo, LJ, Shou, J, et al. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 2009;66:13431348.
12. Leone, M, Garcin, F, Bouvenot, J, et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 2007;35:379385.
13. Wilde, AM, Nailor, MD, Nicolau, DP, et al. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback. Pharmacotherapy 2012;32:755763.
14. Swoboda, SM, Dixon, T, Lipsett, PA. Can the clinical pulmonary infection score impact ICU antibiotic days? Surg Infect 2006;7: 331339.
15. Knaus, WA, Draper, EA, Wagner, DP, et al. APACHE II: a severity of disease classification system. CritCareMed 1985;13:818829.
16. Fagon, JY, Chastre, J, Hance, AJ, et al. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993;103:547553.
17. Chastre, J, Wolff, M, Fagon, JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:25882598.
18. Chastre, J, Viau, F, Brun, P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984; 130:924929.
19. Fabregas, N, Ewig, S, Torres, A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54: 867873.
20. Wunderink, RG, Woldenberg, LS, Zeiss, J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992;101:458463.
21. Balthazar, AB, Von Nowakonski, A, De Capitani, EM, et al. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz J Med Biol Res 2001;34:9931001.
22. Klompas, M. Does this patient have ventilator-associated pneumonia? JAMA 2007;297:15831593.
23. Fartoukh, M, Maitre, B, Honore, S, et al. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003;168:173179.
24. Singh, N, Rogers, P, Atwood, CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505511.
25. Raman, K, Nailor, MD, Nicolau, DP, et al. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. Crit Care Med 2013;41:16561663.
26. Ibrahim, EH, Ward, S, Sherman, G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29:11091115.
27. Micek, ST, Ward, S, Fraser, VJ, et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:17911799.
28. Fagon, JY, Chastre, J, Wolff, M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132:621–30.
29. Shorr, AF, Sherner, JH, Jackson, WL, et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a metaanalysis. Crit Care Med 2005;33:4653.
30. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. Atlanta: Centers for Disease Control and Prevention, 2014. http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed